Transcriptomic and Proteomic Profiling of Circulating Tumor Cells to Identify Predictive Biomarkers of Chemotherapeutic Response in Triple-Negative Breast Cancer. ICMERD-IJMS. 2022;3(1):1-7. Accessed July 14, 2025. https://icmerd.com/index.php/ICMERD-IJMS/article/view/ICMERD-IJMS_03_01_001